IM Cannabis (IMCC) Competitors $2.56 +0.05 (+1.99%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$2.48 -0.08 (-3.13%) As of 08:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCC vs. XCUR, LTRN, ACRV, CGTX, GRCE, MURA, ZIVO, PLUR, STTK, and COEPShould you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Exicure (XCUR), Lantern Pharma (LTRN), Acrivon Therapeutics (ACRV), Cognition Therapeutics (CGTX), Grace Therapeutics (GRCE), Mural Oncology (MURA), ZIVO Bioscience (ZIVO), Pluri (PLUR), Shattuck Labs (STTK), and Coeptis Therapeutics (COEP). These companies are all part of the "pharmaceutical products" industry. IM Cannabis vs. Its Competitors Exicure Lantern Pharma Acrivon Therapeutics Cognition Therapeutics Grace Therapeutics Mural Oncology ZIVO Bioscience Pluri Shattuck Labs Coeptis Therapeutics Exicure (NASDAQ:XCUR) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability. Does the media favor XCUR or IMCC? In the previous week, Exicure had 4 more articles in the media than IM Cannabis. MarketBeat recorded 5 mentions for Exicure and 1 mentions for IM Cannabis. IM Cannabis' average media sentiment score of 0.00 beat Exicure's score of 0.00 indicating that IM Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exicure 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IM Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, XCUR or IMCC? Exicure has a beta of 3.67, meaning that its share price is 267% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 2.2, meaning that its share price is 120% more volatile than the S&P 500. Is XCUR or IMCC more profitable? Exicure has a net margin of 0.00% compared to IM Cannabis' net margin of -9.10%. IM Cannabis' return on equity of -122.96% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets ExicureN/A -219.60% -82.03% IM Cannabis -9.10%-122.96%-11.69% Do institutionals & insiders believe in XCUR or IMCC? 42.8% of Exicure shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 3.9% of Exicure shares are held by company insiders. Comparatively, 5.9% of IM Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger valuation and earnings, XCUR or IMCC? IM Cannabis has higher revenue and earnings than Exicure. IM Cannabis is trading at a lower price-to-earnings ratio than Exicure, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExicureN/AN/A-$9.70M-$3.82-1.93IM Cannabis$54.47M0.19-$7.72M-$0.64-4.00 SummaryIM Cannabis beats Exicure on 7 of the 12 factors compared between the two stocks. Get IM Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCC vs. The Competition Export to ExcelMetricIM CannabisMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.15M$10.35B$5.48B$9.56BDividend YieldN/A2.02%3.99%4.17%P/E Ratio-4.0019.2529.9325.14Price / Sales0.1923.11375.2276.13Price / CashN/A21.8135.9458.58Price / Book2.492.848.105.59Net Income-$7.72M$211.77M$3.26B$265.48M7 Day Performance1.19%1.54%0.68%1.22%1 Month Performance-24.04%2.31%2.45%0.39%1 Year Performance-19.24%-11.48%27.72%23.47% IM Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCCIM Cannabis0.2508 of 5 stars$2.56+2.0%N/A-16.3%$10.15M$54.47M-4.00340Upcoming EarningsGap DownXCURExicure0.8965 of 5 stars$6.63-8.2%N/A+1,340.3%$41.89MN/A-1.7450Positive NewsUpcoming EarningsLTRNLantern Pharma2.289 of 5 stars$3.87-3.5%$25.00+546.0%+23.8%$41.74MN/A-2.1020News CoverageShort Interest ↑ACRVAcrivon Therapeutics2.8202 of 5 stars$1.33-7.0%$17.71+1,231.9%-81.8%$41.70MN/A-0.6058Upcoming EarningsCGTXCognition Therapeutics2.3788 of 5 stars$0.67-6.3%$2.83+322.8%+16.3%$41.55MN/A-0.9120Earnings ReportUpcoming EarningsGRCEGrace TherapeuticsN/A$2.98-1.7%$12.00+302.7%N/A$41.21MN/A-3.35N/APositive NewsMURAMural Oncology2.705 of 5 stars$2.38-1.2%$12.00+404.2%-48.8%$41.10MN/A-0.31119Earnings ReportUpcoming EarningsZIVOZIVO BioscienceN/A$10.70-3.2%N/A+75.6%$40.84M$15.85K-2.1910Upcoming EarningsGap DownPLURPluri2.0765 of 5 stars$5.09-5.4%$12.00+135.8%-13.4%$40.06M$330K-0.92150STTKShattuck Labs3.1737 of 5 stars$0.84+1.7%$7.50+797.9%-74.2%$40.01M$4.61M-0.60100Gap DownCOEPCoeptis TherapeuticsN/A$11.24-6.3%N/A+159.3%$39.45MN/A-1.942 Related Companies and Tools Related Companies XCUR Competitors LTRN Competitors ACRV Competitors CGTX Competitors GRCE Competitors MURA Competitors ZIVO Competitors PLUR Competitors STTK Competitors COEP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
